Paper Details 
Original Abstract of the Article :
AIM: We hypothesized that repeat onabotulinumtoxinA (BTX-A) injections to salivary glands would have a cumulative effect on drooling, leading to prolonged efficacy duration. METHODS: We retrospectively reviewed medical records and conducted a telephone survey of individuals treated with BTX-A to th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/33394592

データ提供:米国国立医学図書館(NLM)

OnabotulinumtoxinA for Sialorrhea: A Cumulative Journey Through the Desert of Drooling

Sialorrhea, excessive drooling, can be a debilitating condition, particularly for individuals with neurological disorders. This study investigates the long-term effects of repeated onabotulinumtoxinA (BTX-A) injections to the salivary glands in patients with cerebral palsy, exploring the potential for cumulative efficacy and prolonged relief from drooling.

The Cumulative Impact of OnabotulinumtoxinA

This retrospective study reveals a potential cumulative effect of repeated BTX-A injections to the salivary glands, resulting in prolonged efficacy duration. Each additional injection was associated with an increase in the duration of efficacy, suggesting that repeated injections may provide longer-lasting relief from drooling. This finding suggests that a cumulative effect might be a beneficial strategy for managing sialorrhea in patients with cerebral palsy.

Navigating the Desert of Sialorrhea Management

This study provides a promising avenue for managing sialorrhea in patients with cerebral palsy. The potential for a cumulative effect of BTX-A injections offers a potential path toward longer-lasting relief and improved quality of life. However, it's crucial to weigh the benefits against potential risks and to closely monitor patients receiving this treatment. As we continue to navigate the desert of sialorrhea management, research like this provides valuable insights into potential solutions for individuals struggling with this challenging condition.

Dr. Camel's Conclusion

This study explores the potential for cumulative efficacy of repeated BTX-A injections to the salivary glands, offering a potential oasis in the desert of sialorrhea management. It suggests that repeated injections might provide longer-lasting relief for patients with cerebral palsy. As we continue to explore the vast desert of neurological conditions, this research provides valuable insights into potential solutions for improving the quality of life for individuals facing these challenges.

Date :
  1. Date Completed 2021-09-08
  2. Date Revised 2021-09-08
Further Info :

Pubmed ID

33394592

DOI: Digital Object Identifier

00002060-202108000-00012

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.